JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Identification of a novel molecular classification for hepatocellular carcinoma based on disulfideptosis-related genes and its potential prognostic significance

  • 0Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwu Weiqi Road, Jinan, 250000, China.
Journal of Cancer Research and Clinical Oncology +

|

November 17, 2024

|

November 17, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

A novel disulfidptosis score aids in predicting hepatocellular carcinoma (HCC) prognosis. This score also helps in guiding immunotherapy strategies for patients with this deadly cancer.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Hepatocellular carcinoma (HCC) is a globally prevalent and lethal malignancy.
  • Disulfidptosis, a novel regulated cell death (RCD) pathway, presents new opportunities for prognostic biomarkers and therapeutic targets in HCC.

Purpose Of The Study

  • To develop a molecular classification for HCC based on disulfidptosis-related genes.
  • To evaluate the association between this classification, tumor immunity, and patient prognosis.

Main Methods

  • Utilized expression data of 14 disulfideptosis-related genes from public databases.
  • Performed cluster analysis on TCGA HCC cohort, identifying three distinct clusters (A, B, C).
  • Constructed a prognostic disulfidptosis score model using differentially expressed genes.

Main Results

  • Disulfidptosis score emerged as an independent prognostic factor for HCC via COX regression analysis.
  • Significant differences in tumor immune microenvironment and immune checkpoint expression were observed across disulfidptosis score groups.

Conclusions

  • The disulfidptosis score is crucial for predicting HCC prognosis.
  • This score can inform and improve immunotherapy selection for HCC patients.

Keywords: